Leah Lawrence

Leah Lawrence is a freelance health writer and editor based in Delaware.

Articles by Leah Lawrence

Leah LawrencePrint | January 13, 2023
With more bispecific antibodies in development for hematologic malignancies, physicians must determine how best use them.
Read More
Leah LawrencePrint | December 22, 2022
Experts discuss areas of progress and where more work is needed to establish a standard of care in mantle cell lymphoma.
Leah LawrenceMeeting News | December 20, 2022
There has been an improvement in the prognosis of older patients diagnosed with acute lymphoblastic leukemia.
Leah LawrenceAcute Myeloid Leukemia | December 19, 2022
Researchers have identified possible resistance mechanisms to gilteritinib plus venetoclax in patients with R/R AML.
Leah LawrenceAcute Myeloid Leukemia | December 19, 2022
Molecular MRD was strongly prognostic in patients with NPM1-mutated AML who received venetoclax-based non-intensive therapy.
Leah LawrenceMyeloma | December 10, 2022
Use of drugs with alternative modes of action may be needed to overcome persistent MRD positivity in myeloma.
Leah LawrenceMeeting News | December 10, 2022
Survivors of lymphoma are at risk for the development of a second primary malignancy, including new lymphomas.
Leah LawrenceMeeting News | December 10, 2022
The bispecific antibody odronextamab had “compelling” efficacy in patients with relapsed or refractory follicular ...
Leah LawrenceMyeloma | December 10, 2022
Selinexor combinations had moderate efficacy in real-world patients with relapsed or refractory multiple myeloma.
Leah LawrenceMeeting News | December 10, 2022
A whole-genome transcriptome sequencing study of hairy cell leukemia revealed a high degree of genomic complexity.